AAAAAA
Results: 1-25/30
Authors:
Julian-Reynier, C
Eisinger, F
Moatti, JP
Sobol, H
Citation: C. Julian-reynier et al., Re: Randomized trial of a specialist genetic assessment service for familial breast cancer, J NAT CANC, 93(2), 2001, pp. 158-159
Authors:
Eisinger, F
Charafe-Jauffret, E
Jacquemier, J
Birnbaum, D
Julian-Reynier, C
Sobol, H
Citation: F. Eisinger et al., Tamoxifen and breast cancer risk in women harboring a BRCA1 germline mutation: computed efficacy, effectiveness and impact, INT J ONCOL, 18(1), 2001, pp. 5-10
Authors:
Eisinger, F
Julian-Reynier, C
Sobol, H
Citation: F. Eisinger et al., The prophylactic mastectomy from a medical, individual and social angle, M S-MED SCI, 17(10), 2001, pp. 1027-1030
Authors:
Jacquemier, J
Lidereau, R
Birnbaum, D
Eisinger, F
Sobol, H
Citation: J. Jacquemier et al., Assessing the risk of BRCA1-associated breast cancer using individual morphological criteria, HISTOPATHOL, 38(4), 2001, pp. 378-379
Authors:
Charafe-Jauffret, E
Eisinger, F
Mathoulin-Portier, MP
Hassoun, J
Birnbaum, D
Sobol, H
Jacquemier, J
Citation: E. Charafe-jauffret et al., PS2-expression in BRCA1-associated breast cancers, ANTICANC R, 21(4B), 2001, pp. 2877-2881
Authors:
Eisinger, F
Julian-Reynier, C
Sobol, H
Citation: F. Eisinger et al., Tamoxifen's effect in women with breast cancer, LANCET, 357(9264), 2001, pp. 1291-1291
Authors:
Eisinger, F
Juliain-Reynier, C
Sobol, H
Citation: F. Eisinger et al., Re: Biologic characteristics of interval and screen-detected breast cancers, J NAT CANC, 92(18), 2000, pp. 1533-1534
Authors:
Julian-Reynier, C
Eisinger, F
Moatti, JP
Sobol, H
Citation: C. Julian-reynier et al., Physicians' attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines, EUR J HUM G, 8(3), 2000, pp. 204-208
Authors:
Orsi, F
Moatti, JP
Eisinger, F
Chabannon, C
Citation: F. Orsi et al., The relationships between public research and the biotechnology industry: appropriate American model European countries?, M S-MED SCI, 16(1), 2000, pp. 94-100
Authors:
Julian-Reynier, C
Bourret, P
Sevilla, C
Eisinger, F
Sobol, H
Moatti, JP
Citation: C. Julian-reynier et al., The new genome consumers, BIOFUTUR, 2000(206), 2000, pp. 100-103
Authors:
Julian-Reynier, C
Eisinger, F
Chabal, F
Lasset, C
Nogues, C
Stoppa-Lyonnet, D
Vennin, P
Sobol, H
Citation: C. Julian-reynier et al., Disclosure to the family of breast/ovarian cancer genetic test results: Patient's willingness and associated factors, AM J MED G, 94(1), 2000, pp. 13-18
Authors:
Julian-Reynier, C
Eisinger, F
Evans, G
Foulkes, W
Sobol, H
Citation: C. Julian-reynier et al., Variation in prophylactic surgery decisions, LANCET, 356(9242), 2000, pp. 1687-1687
Authors:
Eisinger, F
Julian-Reynier, C
Stoppa-Lyonnet, D
Lasset, C
Nogues, C
Citation: F. Eisinger et al., Acceptability of prophylactic mastectomy in cancer-prone women, J AM MED A, 283(2), 2000, pp. 202-203
Authors:
Sobol, H
Jacquemier, J
Bonaiti, C
Dauplat, J
Birnbaum, D
Eisinger, F
Citation: H. Sobol et al., Fallopian tube cancer as a feature of BRCA1-associated syndromes, GYNECOL ONC, 78(2), 2000, pp. 263-264
Authors:
Lidereau, R
Eisinger, F
Champeme, MH
Nogues, C
Bieche, I
Birnbaum, D
Pallud, C
Jacquemier, J
Sobol, H
Citation: R. Lidereau et al., Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer, CANCER RES, 60(5), 2000, pp. 1206-1210
Authors:
Auroy, L
Eisinger, F
Julian-Reynier, C
Citation: L. Auroy et al., Knowledge and management of psychological side effects of chemotherapies, B CANCER, 87(6), 2000, pp. 463-467
Authors:
Eisinger, F
Jacquemier, J
Charafe-Jauffret, E
Rio, MC
Birnbaum, D
Sobol, H
Citation: F. Eisinger et al., More about: Multifactorial analysis of differences between sporadic breastcancers and cancers involving BRCA1 and BRCA2 mutations, J NAT CANC, 91(16), 1999, pp. 1421-1422
Authors:
Eisinger, F
Sobol, H
Citation: F. Eisinger et H. Sobol, Comments on: Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancerclinics, Vasen et al., Eur J Cancer 1998, 34, 1922-1926, EUR J CANC, 35(5), 1999, pp. 859-860
Authors:
Julian-Reynier, C
Eisinger, F
Chabal, F
Aurran, Y
Bignon, YJ
Machelard-Roumagnac, M
Maugard, C
Nogues, C
Vennin, P
Sobol, H
Citation: C. Julian-reynier et al., Cancer genetic consultation and anxiety in healthy consultees, PSYCHOL HEA, 14(3), 1999, pp. 379-390
Authors:
Sobol, H
Bignon, YJ
Bonaiti, C
Cuisenier, J
Lasset, C
Lortholary, A
Nogues, C
Stoppa-Lyonnet, D
Eisinger, F
Citation: H. Sobol et al., Four years analysis of cancer genetic clinics activity in France from 1994to 1997: A survey on 801 patients, DIS MARKER, 15(1-3), 1999, pp. 15-29
Authors:
Eisinger, F
Burke, W
Sobol, H
Citation: F. Eisinger et al., Management of women at high genetic risk of ovarian cancer, LANCET, 354(9190), 1999, pp. 1648-1648
Authors:
Eisinger, F
Geller, G
Burke, W
Holtzman, NA
Citation: F. Eisinger et al., Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer, LANCET, 353(9156), 1999, pp. 919-920
Authors:
Eisinger, F
Nogues, C
Guinebretiere, JM
Peyrat, JP
Bardou, VJ
Noguchi, T
Vennin, P
Sauvin, R
Lidereau, R
Birnbaum, D
Jacquemier, J
Sobol, H
Citation: F. Eisinger et al., Novel indications for BRCA1 screening using individual clinical and morphological features, INT J CANC, 84(3), 1999, pp. 263-267
Authors:
Jacquemier, J
Eisinger, F
Nogues, C
Sun, ZZ
Guinebretiere, JM
Peyrat, JP
Geneix, J
Lidereau, R
Birnbaum, D
Sobol, H
Citation: J. Jacquemier et al., Histological type and syncytial growth pattern affect E-cadherin expression in a multifactorial analysis of a combined panel of sporadic and BRCA1-associated breast cancers, INT J CANC, 83(1), 1999, pp. 45-49
Authors:
Eisinger, F
Jacquemier, J
Nogues, C
Birnbaum, D
Sobol, H
Citation: F. Eisinger et al., Steroid receptors in hereditary breast carcinomas associated with BRCA1 orBRCA2 mutations or unknown susceptibility genes, CANCER, 85(10), 1999, pp. 2291-2293